Warren Remedies, a subsidiary, wholly owned by Indoco Remedies, has initiated its commercial operations on March 24, 2024, at its newly established facility located in Aurangabad, Maharashtra. The facility is dedicated to the production of pharmaceutical intermediates and active pharmaceutical ingredients (APIs).
The establishment of the facility enhances the company’s capacity to meet the growing requirements for APIs. Indoco Remedies, a research-driven pharmaceutical enterprise, boasts a comprehensive portfolio of pharmaceutical products tailored for both domestic and international markets, with a presence spanning across 55 countries.
The company operates nine manufacturing units, comprising six dedicated to finished dosage forms (FDFs) and three specializing in APIs. The facilities are complemented by an advanced R&D center and a Contract Research Organization (CRO) facility. As reported by PROJECTS TODAY, the manufacturing units have obtained approvals from various regulatory authorities.
